T he large-conductance Ca 2+ -activated K + (BK Ca ) channel is essential in the control of vascular tone. The BK Ca channel in vascular smooth muscle cells (VSMCs) exists as an assembly of pore-forming α, and auxiliary β1 subunits, encoded by KCNMA1 and KCNMB1, respectively.
T he large-conductance Ca 2+ -activated K + (BK Ca ) channel is essential in the control of vascular tone. The BK Ca channel in vascular smooth muscle cells (VSMCs) exists as an assembly of pore-forming α, and auxiliary β1 subunits, encoded by KCNMA1 and KCNMB1, respectively. 1 Activation of the BK Ca channel in VSMCs is primarily stimulated by an increase in intracellular Ca 2+ concentrations. 2 The β1 subunit enhances BK Ca channel activity by increasing the intrinsic Ca 2+ sensitivity of the α subunit. 3 Because of its large conductance and high density in VSMCs, activation of the BK Ca channel exhibits an immense effect on membrane potential. Therefore, the BK Ca channel functions as a key determinant in the regulation of vascular tone. 2, 4, 5 Lines of evidence have suggested a critical importance of the β1 subunit in the regulation of BK Ca channel function. Mice deficient in KCNMB1 displayed impaired vasorelaxation and elevated blood pressure. 6, 7 In addition, a gain-of-function mutation of the β1 subunit is associated with a low prevalence of diastolic hypertension in humans. 8 The uterine circulation undergoes significant hemodynamic changes during the course of pregnancy, and uterine blood flow increases dramatically to meet the demand of fetal growth and development. [9] [10] [11] Maladaptation and inadequate perfusion of the uterus and placenta during pregnancy are associated with high incidence of clinical complications, including preeclampsia and fetal intrauterine growth restriction. [12] [13] [14] The upregulation of BK Ca channel β1 subunit expression and enhanced BK Ca channel function plays a key role in the reduction of uterine vascular tone and the hemodynamic adaptation of uterine circulation during pregnancy. [15] [16] [17] [18] Of importance, steroid hormone estrogen was found to be the initiator of pregnancy-induced BK Ca channel β1 subunit upregulation. 18, 19 In addition to pregnancy, a variety of physiological and pathophysiological conditions such as hypertension, aging, diabetes mellitus, chronic hypoxia, shock, Abstract-The large-conductance Ca 2+ -activated K + (BK Ca ) channel is of critical importance in pregnancy-mediated increase in uterine artery vasodilation and blood flow. The present study tested the hypothesis that active DNA demethylation plays a key role in pregnancy-induced reprogramming and upregulation of BK Ca channel β1 subunit (BKβ1) in uterine arteries. Uterine arteries were isolated from nonpregnant and near-term pregnant sheep. Pregnancy significantly increased the expression of ten-eleven translocation methylcytosine dioxygenase 1 (TET1) in uterine arteries. A half-palindromic estrogen response element was identified at the TET1 promoter, and estrogen treatment increased TET1 promoter activity and TET1 expression in uterine arteries. In accordance, pregnancy and steroid hormone treatment resulted in demethylation of BKβ1 promoter by increasing 5-hydroxymethylcytosine and decreasing 5-methylcytosine at the CpG in the Sp1 -380 binding site that is of critical importance in the regulation of the promoter activity and BKβ1 expression. Inhibition of TET1 with fumarate significantly decreased BKβ1 expression in uterine arteries of pregnant animals and blocked steroid hormone-induced upregulation of BKβ1. Functionally, fumarate treatment inhibited pregnancy and steroid hormoneinduced increases in BK Ca channel current density and BK Ca channel-mediated relaxations. In addition, fumarate blocked pregnancy and steroid hormone-induced decrease in pressure-dependent myogenic tone of the uterine artery. The results demonstrate a novel mechanism of estrogen-mediated active DNA demethylation in reprogramming of BK Ca channel expression and function in the adaption of uterine circulation during pregnancy. (Hypertension. 2017;69:1181-1191.
and obesity also alter vascular function in human and in animal models by regulating BK Ca channel β1 subunit expression and channel activity in VSMCs.. [20] [21] [22] [23] [24] [25] [26] [27] [28] However, molecular mechanisms underlying these changes remain elusive.
It is now well recognized that epigenetic modifications including DNA methylation, histone modification, and RNAbased mechanisms controlled by small noncoding micro-RNAs contribute to the regulation of cardiovascular function and pathogenesis of cardiovascular diseases. 29 Our recent studies revealed that DNA methylation played a central role in regulating KCNMB1 expression in uterine arteries during pregnancy. 30, 31 The Sp1 binding site (Sp1 -380 ) at the KCNMB1 promoter was hypermethylated in uterine arteries of nonpregnant sheep, which impeded transcription factor binding and suppressed KCNMB1 expression. However, pregnancy triggered a decrease in CpG methylation at Sp1 -380 and increased estrogen receptor alpha (ERα) and Sp1 binding, leading to enhanced KCNMB1 expression. Interestingly, steroid hormone treatment of uterine arteries from nonpregnant animals also promoted demethylation at the Sp1 -380 site, imitating the effects of pregnancy. Nevertheless, the mechanisms underlying KCNMB1 promoter demethylation in uterine arteries during pregnancy have not been determined.
DNA demethylation could take place via active or passive processes. 32 Active demethylation removes the methyl group from 5-methylcytosine (5mC) via enzymatic processes, whereas passive demethylation occurs because of loss of 5mC during successive rounds of replication in the absence of maintenance methylation activity. Recent evidence suggests an important role of the ten-eleven translocation (TET) methylcytosine dioxygenases in active DNA demethylation. [32] [33] [34] TETs catalyze the conversion of 5mC to 5-hydroxymethylcytosine, and 5-hydroxymethylcytosine undergoes further oxidation and deamination conferred by TETs, thymine-DNA glycosylase, and base excision repair machinery, resulting in an unmethylated cytosine. Herein, we present novel evidence that estrogen upregulates TET enzymes in uterine arteries, which subsequently promotes active demethylation, leading to reprogramming of BK Ca channel upregulation in uterine arteries during pregnancy.
Methods
All procedures and protocols were approved by the Institutional Animal Care and Use Committee of Loma Linda University and followed the guidelines by the National Institutes of Health Guide for the Care and Use of Laboratory Animals. After tissue collection, animals were killed via intravenous injection of 15-mL T-61 solution (Hoechst-Rousel, Somervile, NJ), according to American Veterinary Medical Association guidelines.
Tissue Preparation and Treatment
Uterine arteries were harvested from nonpregnant and near-term (≈142-145 days of gestation) pregnant sheep (Ovis aries). 35, 36 Animals were anesthetized with intravenous injection of propofol (2 mg/kg) followed by intubation, and anesthesia was maintained on 1.5% to 3.0% isoflurane balanced in O 2 throughout the surgery. An incision was made in the abdomen, and the uterus was exposed. The fourth-generation branches of main uterine artery were isolated and removed without stretching and placed into a Krebs solution containing (in mmol/L) 130.0 NaCl, 10.0 HEPES, 6.0 glucose, 4.0 KCl, 4.0 NaHCO 3 , 1.8 CaCl 2 , 1.2 MgSO 4 , 1.18 KH 2 PO 4 , and 0.025 EDTA (pH 7.4). Uterine arteries were placed in a culture dish containing 5 mL of phenol redfree Dulbecco's Modified Eagle Medium supplemented with 1% charcoal-stripped fetal bovine serum, 100-U/mL penicillin, and 100-μg/mL streptomycin and incubated at 37°C in humidified incubators for 48 hours, as described previously. 27, 36, 37 For the hormonal treatment, uterine arteries from nonpregnant sheep were incubated in the absence or presence of 17β-estradiol (E2ββ; 0.3 nmol/L; Sigma) and progesterone (P4; 100.0 nmol/L; Sigma), as reported previously. 27, 36, 37 
Measurement of BK Ca Channel Current
Arterial smooth muscle cells were enzymatically dissociated from resistance-sized uterine arteries, and whole-cell K + currents were recorded using an EPC 10 patch-clamp amplifier with Patchmaster software (HEKA; Lambrecht/Pfalz, Germany) at room temperature as described previously. 18, 27 Briefly, cell suspension drops were placed in a recording chamber, and adherent cells were continuously superfused with HEPES-buffered physiological salt solution containing (in mmol/L) 140.0 NaCl, 5.0 KCl, 1.8 CaCl 2 , 1.2 MgCl 2 , 10.0 HEPES, and 10.0 glucose (pH 7.4). Only relaxed and spindle-shaped myocytes were used for recording. Micropipettes were pulled from borosilicate glass and had resistances of 2 to 5 mΩ when filled with the pipette solution containing (in mmol/L) 140.0 KCl, 1.0 MgCl 2 , 5.0 Na 2 ATP, 5.0 EGTA, 10.0 HEPES (pH 7.2). CaCl 2 was added to bring free Ca 2+ concentrations to 100 nmol/L as determined using WinMAXC software (Chris Patton, Stanford University). Cells were held at -50 mV, and whole-cell K + currents were evoked by voltage steps from −60 to +80 mV by stepwise 10-mV depolarizing pulses (350-ms duration, 10-second intervals) in the absence and presence of 1 mmol/L BK Ca channel blocker tetraethylammonium.
18,27 BK Ca currents, determined as the difference between whole-cell K + currents in the absence of tetraethylammonium and that in the presence of tetraethylammonium, were normalized to cell capacitance and expressed as picoampere per picofarad (pA/pF).
Relaxation Studies
Uterine arteries were separated from surrounding tissues and cut into 2-mm ring segments. Isometric tension was measured in the Krebs solution in a tissue bath system (Radnoti, Monrovia, CA) at 37°C as described previously. 36, 38 Briefly, each ring segment was equilibrated for 60 minutes and then gradually stretched to the optimal resting tension determined by responses to 3×120 mmol/L KCl challenges. Tissues were then precontracted with submaximal concentrations of serotonin that produced ≈70% to 80% of the maximal contraction, followed by additions of the BK Ca channel opener NS1619 in a cumulative manner.
Measurement of Pressure-Dependent Myogenic Tone
Pressure-dependent myogenic tone of resistance-sized uterine arteries was measured as described previously. 18, 36 Briefly, the arterial segments (diameter ≈150 μm) were mounted and pressurized in an organ chamber (Living Systems Instruments, Burlington, VT). The intraluminal pressure was controlled by a servo-system to set transmural pressures, and arterial diameter was recorded using the SoftEdge Acquisition Subsystem (IonOptix LLC, Milton, MA). After the equilibration period, the intraluminal pressure was increased in a stepwise manner from 10 to 100 mm Hg in 10-mm Hg increments, and each pressure was maintained for 5 minutes to allow vessel diameter to stabilize before the measurement. The passive pressure-diameter relationship was conducted in Ca 2+ -free PSS containing 3.0 mmol/L of EGTA to determine the maximum passive diameter. The following formula was used to calculate the percentage of pressure-dependent tone at each pressure step: % tone=(D1−D2)/D1×100, where D1 is the passive diameter in Ca 
Real-Time Real-Time-Polymerase Chain Reaction
Total RNA was isolated using TRIzol reagent (Invitrogen, CA) and subjected to reverse transcription with iScript cDNA Synthesis system (Bio-Rad, Hercules, CA). The abundance of TET mRNA was measured with real-time polymerase chain reaction (PCR) using iQ SYBR Green Supermix (Bio-Rad), as described previously. 30 Primers used were 5′-acactagaacaagtagtggcaata-3′ (forward) and 5′-tttaagtttgggtcttggaggtct-3′ (reverse) for TET1 and 5′-ctgtaccacacggaggacact-3′ (forward) and 5′-gtagaggcgctggaataggac-3′ (reverse) for BK Ca channel β1 subunit. Real-time PCR was performed in a final volume of 25 μL, and each PCR reaction mixture consisted of 500 nmol/L of primers and iQ SYBR Green Supermix containing 0.625 U hot-start Taq polymerase; 400 μmol/L each of dATP, dCTP, dGTP, and dTTP; 100 mmol/L KCl; 16.6 mmol/L ammonium sulfate; 40 mmol/L TrisHCl; 6 mmol/L MgSO 4 ; SYBR Green I; and 20 nmol/L fluorescing and stabilizers. The following protocol was used for real-time PCR: 95°C for 5 minutes, followed by 45 cycles of 95°C for 30 seconds and annealing for 30 seconds at 52°C and for 45 seconds at 72°C. GAPDH was used as an internal reference, and serial dilutions of the positive control were performed on each plate to create a standard curve for the quantification. PCR was performed in triplicate, and threshold cycle numbers were averaged for each sample.
Western Immunoblotting
Protein abundance of TET1 and BK Ca channel β1 subunit in uterine arteries was measured as described previously. 18, 27 Briefly, tissues were homogenized in a lysis buffer followed by centrifugation at 4°C for 10 minutes at 10 000g, and the supernatants were collected. Samples with equal proteins were loaded onto 7.5% polyacrylamide gel with 0.1% SDS and were separated by electrophoresis at 100 V for 2 hours. Proteins were then transferred onto nitrocellulose membranes. After blocking nonspecific binding sites by dry milk, membranes were incubated with primary antibodies against TET1 (Millipore, Billerica, MA) and BK Ca channel β1 subunit (Santa Cruz Biotechnology, Santa Cruz, CA). After washing, membranes were incubated with secondary horseradish peroxidase-conjugated antibodies. Proteins were visualized with enhanced chemiluminescence reagents, and blots were exposed to Hyperfilm. Results were quantified with the Kodak electrophoresis documentation and analysis system and Kodak ID image analysis software (Kodak, Rochester, NY). The target protein abundance was normalized to the abundance of β-actin as a protein loading control.
Cloning of Ovine TET1 Promoter
The sequence information of the ovine TET methylcytosine dioxygenase 1 (TET1) gene may be obtained from NCBI (http://www.ncbi. nlm.nih.gov/gene/101103534). A 1918-bp fragment of ovine TET1 promoter region spanning −1898 to +20 bp relative to transcriptional start site was cloned using ovine genomic DNA (100 ng) as template for DNA amplification. Primers used for DNA amplification reaction were: 5′-ttaaaattttgtatctcatgtgttgct-3′ (forward) and 5′-acgaagtaggaaaatctgaaagg-3′ (reverse). The amplified DNA fragment was gel purified, rapid cloned in pCR4-TOPO, and sequence confirmed. The promoter sequence matched with GenBank promoter sequence information. Subsequently, the TET1 sequence was directionally cloned 5′ (Kpn I) to 3′ (XhoI) into pGL3 basic vector (Promega) to create a TET1 promoter-pGL3 reporter construct, using following primers: 5′-gagacccggtaccaaattttgtatctcatgtgttgct-3′ (forward) and 5′-gagacccctcgagacgaagtaggaaaatctgaaagg-3′ (reverse), where ggtacc and ctcgag are Kpn I and Xho I sites, respectively, and created artificially in the primers to facilitate cloning. The sequence of TET1 promoter in reporter construct was reconfirmed by sequencing and used for reporter gene assay.
Reporter Gene Assay
Smooth muscle cells isolated from uterine arteries of nonpregnant sheep were cultured in Dulbecco's Modified Eagle Medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin at 37°C, as described previously. 30, 37 At ≈70% confluence, cells were subcultured in 24-well plates and then transiently cotransfected with 0.5 μg of TET1 promoter-pGL3 reporter construct along with 0.05 μg of pRL-SV40 Luc plasmid (Promega, Madison, WI) using X-treme GENE HP DNA transfection reagent (Roche) following the manufacturer's instructions. On the second day, the medium on the cells was replaced with the fresh media without or with 17β-estradiol (0.3 nmol/L) and progesterone (100.0 nmol/L). After 48 hours, firefly and Renilla reniformis luciferase activities in cell extracts were measured in a luminometer using a dual-luciferase reporter assay system (Promega), as described previously. 30, 37 Promoter activities were then calculated by normalizing the firefly luciferase activities to R. reniformis luciferase activity.
Hydroxymethylated DNA Immunoprecipitation
Hydroxymethylated DNA immunoprecipitation assay was performed using hydroxymethylated DNA immunoprecipitation kit (Active Motif, Carlsbad, CA) following the manufacturer's instructions with minor modifications. Briefly, sheep genomic DNA was isolated and purified from uterine arteries using Gen Elute Mammalian Genomic DNA kit (Sigma, St. Louis, MO). Ten micrograms of genomic DNA was mechanically fragmented by a sonicator to 200-to 600-bp range and confirmed by 2% agarose gel electrophoresis. The fragmented DNA were then denatured at 95°C and subjected to immunoprecipitation using 5-hydroxymethylcytidine (5hmC) polyclonal antibody supplied in the kit. The hydroxyl-methylated DNA fragments were next pulled down and purified by protein G magnetic beads, phenolchloroform-isoamyl alcohol extracted and ethanol precipitated with 20-μL glycogen as coprecipitant. The precipitate was finally washed, dried, and reconstituted in 30-μL TE buffer. Three microliters of the 5hmC antibody-enriched DNA fragments were next subjected to quantitative real-time PCR on IQ5 (Bio-Rad), using primers flanking the Sp1 -380 binding site of the sheep KCNMB1 promoter: 5′-gtcaaaggctgagggttttg-3′ (forward), and 5′-ggaggaggagtggaagctct-3′ (reverse) as described previously. 30 Parallel to the enrichment of the 5hmC antibody-enriched DNA fragments, a second aliquot of each kind of fragmented genomic DNA (80 ng) were first heat denatured for 10 minutes, cooled the same way as the immunoprecipitated DNA, and then processed similarly but without the 5hmC antibody-protein G step to generate the input DNA. Finally, the input DNA was phenolchloroform-isoamyl alcohol extracted and ethanol precipitated with 20-μL glycogen. The precipitate was washed, dried, and reconstituted in 30-μL TE buffer. Three microliters of processed input DNA was in parallel subjected to quantitative real-time PCR using the same PCR primer pairs flanking the Sp1 -380 binding site in the sheep KCNMB1 promoter. In each 5hmC antibody-enriched DNA sample, the abundance of hydroxyl-methylated DNA was first calculated as fold of corresponding input DNA. Finally, the relative abundance of 5hmC in ovine KCNMB1 promoter under various treatment conditions was expressed as either % of NPUA or % control.
Quantitative Methylation-Specific PCR
Genomic DNA was isolated from uterine arteries using a GenElute Mammalian Genomic DNA Mini-Prep kit (Sigma), denatured with 2 N NaOH at 42°C for 15 minutes and treated with sodium bisulfite at 55°C for 16 hours, as described previously. 30 DNA was purified with a Wizard DNA clean-up system (Promega) and dissolved in 120 μL of H 2 O. Bisulfite-treated DNA was used as a template for real-time fluorogenic methylation-specific PCR using specific primers (Sp1 -380 UMF: 5′-gggttttggttgttgggt-3′, Sp1 -380 UMR: 5′-atttcttcttcacttaatctctctaaac-3′, Sp1 -380 MF: 5′-gggttttggttgttgggc-3′) designed to amplify the regions of interest with unmethylated CpG dinucleotides or methylated CpG dinucleotides, respectively. Real-time methylation-specific PCR was performed using the iQ SYBR Green Supermix with iCycler real-time PCR system (Bio-Rad). Data are presented as the percent of methylation at the Sp1 -380 site of the KCNMB1 promoter (methylated CpG/methylated CpG+unmethylated CpG×100).
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were performed using the ChIP-IT Express kit (Active Motif) as described previously. 37 In brief, sheep uterine artery tissues were first fixed by 1% formaldehyde in 1× PBS for 20 minutes to cross-link and stabilize DNA-protein interactions. The cross-linking reaction was stopped with glycine. The tissues were washed, and chromatin were isolated and sheared into fragments ranging 100 to 1000 bp using a sonicator. ChIP procedure was performed using 2-μL antimethylcytosine dioxygenase (TET1) antibody (Millipore) and protein G magnetic beads to pull down the enzyme-DNA complex. The cross-linking was then reversed, proteins were digested with 2-μL proteinase K (37°C, 1 hour) . The reaction was terminated by addition of 2-μL proteinase K stop solution. Ten microliters of protein-free DNA fragments was subsequently PCR amplified (initial denaturation: 5 minutes at 95°C, followed by 45 cycles of 95°C for 30 seconds, 55°C for 30 seconds, and 72°C for 45 seconds, and completing with final step at 72°C for 2 minutes), using primers flanking the Sp1 -380 binding site of the sheep KCNMB1 promoter; forward: 5′-gtcaaaggctgagggttttg, and reverse: 5′-ggaggaggagtggaagctct. The PCR-amplified product was electrophoresed on a 2% agarose gel (in 1× TBE) stained with ethidium bromide along with 10 μL of 100-bp molecular weight ruler (Bio-Rad, Hercules, CA).
Knockdown of TET1 and BK
was also included. Subsequently, freshly isolated VSMCs were added on top of the mixture and maintained in an incubator at 37°C for 48 hours. The working concentrations of siRNAs applied were 100 nmol/L for target or scrambled siRNAs and 20 nmol/L for fluoresceinlabeled negative control siRNA, respectively.
Probing Roles of TETs in Regulating BK Ca Channel Expression and Function With the Pharmacological Tool Fumarate
The functional importance of TETs was also investigated using the pharmacological tool fumarate. Fumarate, an intermediate in the citric acid cycle, competitively inhibits TETs with an IC 50 of ≈1.5 mmol/L and has been widely used as a pharmacological tool to explore TET-mediated active demethylation. [39] [40] [41] To this end, uterine arteries were cultured in the absence or presence of 3.0 mmol/L cellpermeable fumarate derivative monomethyl fumarate at 37°C for 48 hours. Biochemical and functional studies were subsequently conducted following the treatment.
Statistical Analysis
Data were expressed as means±SEM. obtained from the number of experimental animals given. Concentration-response curves were analyzed by computer-assisted nonlinear regression to fit the data using GraphPad Prism (GraphPad Software, San Diego, CA). Differences were evaluated for statistical significance (P<0.05) by ANOVA or t test where appropriate; and the concentration-response relationship was analyzed with repeated-measure ANOVA.
Results

Pregnancy and Steroid Hormones Upregulated TET1 Expression in Uterine Arteries
Our previous studies demonstrated that pregnancy promoted demethylation of the Sp1 -380 site at the KCNMB1 promoter and subsequently enhanced KCNMB1 expression in uterine arteries. 18, 30, 31 Given that the TET family enzymes have recently been implicated in active DNA demethylation and gene transcription, [32] [33] [34] we examined TET1 expression in uterine arteries of nonpregnant and pregnant sheep. As shown in Figure 1A , pregnancy significantly increased mRNA and protein abundance of TET1 in uterine arteries. Pregnancy increases estrogen levels 42, 43 and estrogen treatment promoted demethylation of the KCNMB1 promoter in uterine arteries. 30 We then determined whether steroid hormones could upregulate TET1. In a manner similar to pregnancy, ex vivo treatment of uterine arteries from nonpregnant sheep with estrogen and progesterone significantly elevated TET1 mRNA and protein abundance ( Figure 1B) . The effects of estrogen are mediated through estrogen receptors that bind to estrogen response elements located in the promoter of target genes to transactivate gene expression in response to estrogen. 44 Ovine TET1 gene promoter contains an estrogen response element half-palindromic 5′-TGACC-3′ motifs at −1370, 5′-upstream of the transcription start site ( Figure 1C ; Figure S1 in the online-only Data Supplement). The luciferase reporter gene assay was performed to determine the regulatory action of estrogen on the TET1 promotor activity in uterine arterial smooth muscle cells. As shown in Figure 1C , steroid hormone treatment significantly increased the activity of TET1 promotor, suggesting a stimulatory role of estrogen in driving the transcription of the ovine TET1 promoter.
TET1 Directly Interacted With KCNMB1 Promoter to Stimulate Demethylation
The interaction between TET1 and KCNMB1 promoter was determined with a ChIP-PCR assay using TET1 antibody to pull down the enzyme-DNA complex. Visualization of ChIP-PCR-amplified products on agarose gel stained with ethidium bromide revealed that TET1 directly interacted with the Sp1 -380 site at the ovine KCNMB1 promoter (Figure 2A ). Given that TET1 oxidizes 5mC to 5hmC, we quantified levels of 5mC and 5hmC at the CpG in the core Sp1 -380 binding site. As shown in Figure 2B , 5hmC abundance at the Sp1 -380 site was significantly greater in uterine arteries from pregnant sheep than that in arteries from nonpregnant sheep. Moreover, the ex vivo steroid hormone treatment of uterine arteries from nonpregnant animals significantly increased 5hmC levels at the CpG in Sp1 -380 binding site ( Figure 2B ). Conversely, the methylation level at the Sp1 -380 site was significantly reduced after the hormonal treatment ( Figure 2C ).
Fumarate Suppressed β1 Subunit Expression and BK Ca Channel Activity in Uterine Arteries
Fumarate is a competitive inhibitor of TET. [39] [40] [41] We thus examined the causal effect of TET1 in regulating BK Ca channel β1 subunit expression and channel activity by inhibition of TET1 using fumarate. Treatment of uterine arteries from pregnant sheep with fumarate for 48 hours reduced expression of BK Ca channel β1 subunit mRNA and protein by 75% and 60%, respectively (P<0.05; Figure 3A ). In the absence of fumarate, ex vivo steroid hormone treatment upregulated BK Ca channel β1 subunit expression in uterine arteries of nonpregnant sheep ( Figure 3B ), as reported in our previous studies. 18, 30, 31 Of interest, fumarate ablated the steroid hormone-mediated effect ( Figure 3B ). Functional consequences of the fumarate treatment were also examined. The fumarate treatment significantly decreased BK Ca channel current densities (eg, 16.0±1.4 versus 27.6±1.3 pA/pF at +80 mV; P<0.05) in uterine arteries of pregnant animals ( Figure 4A ). As shown in Figure 4B , steroid hormone treatment significantly increased BK Ca channel current density in uterine arteries (eg, 29.2±3.5 versus 14.8±1.8 pA/pF at +80 mV; P<0.05). However, fumarate blocked the hormonal effect in the regulation of BK Ca channel activity (eg, 16.0±1.5 versus 13.5±1.5 pA/pF at +80 mV; P>0.05; Figure 4C ).
Knockdown of TET1 Inhibited BK Ca Channel Activity
To ascertain the role of TET1 in regulating BK Ca channel expression and function, TET1 was knocked down by siRNAs in uterine arteries. As shown in Figure 5A , TET1 siRNAs reduced the expression of TET1 mRNA and protein by ≈60%. Of importance, knockdown of TET1 with TET1 siRNAs significantly decreased the expression of BK Ca channel β1 subunit mRNA and protein ( Figure 5A ). Not surprisingly, KCNMB1 siRNAs reduced the expression of BK Ca channel β1 subunit mRNA and protein by ≈80% and 50% ( Figure 5B) . Consistent with the reduced expression of BK Ca channel β1 subunit, TET1 siRNAs or KCNMB1 siRNAs suppressed BK Ca channel currents in uterine arterial smooth muscle cells by ≈40% and ≈50%, respectively ( Figure 5C ).
Fumarate Impaired BK Ca Channel-Mediated Relaxations of Uterine Arteries
We then determined whether the demethylation catalyzed by TET1 played a role in regulating BK Ca channel-mediated relaxations in uterine arteries using the pharmacological inhibitor fumarate. As shown in Figure 6A , the BK Ca channel opener NS1619 induced concentration-dependent relaxations of uterine arteries of pregnant sheep. Fumarate significantly inhibited NS1619-induced relaxations. In uterine arteries of nonpregnant animals, NS1619-induced relaxations were reduced as compared with those in pregnant animals, which were significantly increased with steroid hormone treatment in the absence of fumarate ( Figure 6B ). Of importance in the presence of fumarate, the hormonal treatment failed to augment NS1619-induced relaxations ( Figure 6C ). 
Fumarate Elevated Pressure-Dependent Myogenic Tone of Uterine Arteries
Given the important role of BK Ca channels in regulating of uterine vascular myogenic tone, 18 we further examined the role of demethylation in pregnancy-and steroid hormone-induced decrease in pressure-dependent myogenic tone of uterine arteries. As shown in Figure 6D , fumarate treatment markedly increased pressure-dependent myogenic tone in uterine arteries of pregnant sheep. Consistent with previous studies, 45 the steroid hormone treatment of uterine arteries of nonpregnant sheep significantly decreased pressure-dependent myogenic tone in the absence of fumarate ( Figure 6E) . However, the fumarate treatment annulled this hormone-induced attenuation of uterine vascular tone ( Figure 6F ).
Discussion
The present study revealed a novel mechanism of TET1-mediated active DNA demethylation in steroid hormoneinduced adaptation of BK Ca channel expression and function in uterine arteries in pregnancy. We demonstrated that estrogen transactivated TET1 promoter and increased TET1 expression in uterine arteries. TET1 interacted with KCNMB1 promoter and decreased CpG methylation at the Sp1 -380 binding site, leading to enhanced BK Ca channel β1 subunit expression. Importantly, suppression of TET1 with fumarate and siRNAs reduced β1 subunit expression and BK Ca channel activity in uterine arteries of pregnant sheep and abrogated steroid hormone-induced upregulation of BK Ca channel β1 subunit and channel activity in uterine arteries of nonpregnant animals. Thus, our findings provide new insights in the molecular mechanisms of steroid hormone-regulating active DNA demethylation in uterine vascular adaptation in pregnancy.
DNA methylation is thought to be relatively stable and mediates long-term gene silencing. However, recent new discoveries indicate that DNA methylation is dynamic and reversible, which are crucial to the epigenetic regulation of many key developmental processes including genomic imprinting and gene regulation. 46 Dramatic changes in uterine vascular function and hemodynamics occur during pregnancy, and it is well established that estrogen is the primary mediator of these adaptations. 47, 48 Estrogen usually alters cellular functions by binding to its receptors to alter gene expression. Upregulation of KCNMB1 expression by estrogen plays a pivotal role in reducing uterine vascular tone and increasing uterine blood flow during pregnancy. [15] [16] [17] [18] Recently, we demonstrated that pregnancy-induced upregulation of KCNMB1 was mediated by estrogen-triggered demethylation at the Sp1 -380 site of the KCNMB1 promoter. 30 Pregnancy also promoted demethylation of the Sp1 -520 site at the ESR1 promoter, thereby increasing ERα expression in uterine arteries. 37 Similarly, estrogen exposure promoted demethylation of other estrogen responsive genes including vitellogenin, CRHR2, and pS2 genes in other cells and tissues. [49] [50] [51] [52] [53] However, it remains unresolved how estrogen initiates demethylation. TET family enzymes have recently been implicated in active DNA demethylation. 32, 46, 54 The expression of TETs has been observed in human coronary and mouse femoral arteries as well as in human myometrium. 55, 56 The present study revealed the presence of TET1 in uterine arteries, suggesting that this vasculature possesses an active demethylation machinery. By comparing abundance of TET protein and mRNA in uterine arteries of nonpregnant and pregnant sheep, we demonstrated that pregnancy significantly elevated expression of TET1 in uterine arteries. An estrogen response element half-palindromic 5′-TGACC-3′ motifs is identified at −1370 of the TET1 promoter, and estrogen in conjugation with progesterone to mimic pregnancyinduced increase in both hormones stimulated the promoter activity. The bioinformatics analysis revealed that there is no progesterone response element in the ovine TET1 promoter.
The further promoter analysis with the site-specific deletion or mutation of estrogen response element on the TET1 promoter activity is under current investigation. The modest but significant increase of ≈50% in TET1 promoter activity by the hormone treatment is comparable to the previous finding of estrogen-induced increase in the ESR1 promoter activity in uterine arteries. 37 Of importance, the hormonal treatment of uterine arteries of nonpregnant animals also promoted expression of TET1, replicating the effects of pregnancy. These findings thus implicate estrogen as an initiator of upregulation of TET1 in uterine arteries during pregnancy. Likewise, upregulation of TETs was reported in human uterine leiomyoma, 56 which was possibly mediated by estrogen as this steroid hormone promoted the growth of leiomyoma. 57 TETs catalyze the conversion of 5mC to 5hmC, and the latter undergoes further oxidation and deamination resulting in ultimate demethylation. 32, 46, 54 We showed that TET1 was able to bind to the Sp1 -380 site of the KCNMB1 promoter. Not surprisingly, elevated TET1 expression correlated with increased 5hmC level at the expense of 5mC at this site in uterine arteries of pregnant sheep compared with those of nonpregnant animals, suggesting enhanced conversion of 5mC to 5hmC (ie, active demethylation) owing to TET1 upregulation during pregnancy. In parallel, the hormonal treatment of uterine arteries from nonpregnant animals also triggered a similar demethylation at this site. Thus, our results suggest that estrogen-induced upregulation of TET1 in uterine arteries is responsible for initiating the active demethylation of the KCNMB1 in uterine arteries during pregnancy. Active demethylation by TET1 also occurred in central nervous system and participates in synaptic plasticity and memory formation. [58] [59] [60] In addition, estrogen could facilitate active demethylation by targeting thymine DNA glycosylase to the hypermethylated site via activation of ERβ. 61 Passive demethylation, occurring because of the loss of maintenance methylation activity conferred by DNA methyltransferases, may also contribute to relieving gene repression. 62, 63 The potential involvement of passive demethylation in regulating KCNMB1 expression in pregnancy could not be excluded and merits further investigation.
DNA methylation represents an epigenetic barrier for gene transcription in mammalian and accumulation of 5mC at gene promoters usually represses gene expression. Oxidation of 5mC to 5hmC by TETs is an attractive pathway for methylation erasure, allowing for active removal of 5mC. Elevated 5hmC levels are often associated with increased gene expression. ERα activated by estrogen could tether with Sp1 to bind to demethylated Sp1 -380 site of KCNMB1 promoter, resulting in upregulation of KCNMB1. 30, 31 Thus, the resultant demethylation at this site would enable estrogen to directly exert its regulation of KCNMB1 expression. Consistently, the methylation at the Sp1 -380 site suppressed both binding of transcript factors Sp1 and ERα and KCNMB1 promotor activity, whereas pregnancy and hormonal treatment promoted demethylation at this site and increased Sp1 and ERα binding leading to KCNMB1 upregulation. 30, 31 It would be of interest to be able to demonstrate that the epigenetic regulation of TET1 and KCNMB1 by steroid hormones is reversible in prolonged (days) treatments of uterine arteries after removal of the hormones, albeit it is somewhat challenging in the feasibility of the approach given a possible phenotypic change with the prolonged ex vivo treatments of arteries. Nonetheless, the present study suggests that the methylation status of the KCNMB1 promoter and the expression of BK Ca channel β1 subunit are dynamically regulated in uterine arteries under physiological conditions such as pregnancy.
The upregulation of KCNMB1 in uterine arteries plays a critical role in the adaptive changes of uterine hemodynamics during pregnancy. We demonstrated that the elevated expression of KCNMB1 increased BK Ca channel activity and function in uterine arteries of pregnant sheep, resulting in decreased uterine vascular tone. 18 This is consistent with the finding that local infusion of the BK Ca channel blocker tetraethylammonium reduced basal uterine blood flow in pregnant sheep, but not in nonpregnant sheep. 15, 17, 64 In the present study, we have shown that inhibition of TETs by fumarate or knocking down TET1 with siRNAs specifically nullified pregnancy-and steroid hormoneinduced upregulation of BK Ca channel β1 subunit expression and channel activity. In agreement with these findings, fumarate also eliminated pregnancy-and steroid hormone-induced enhancement of BK Ca channel-mediated relaxations and attenuation of uterine vascular tone. These observations provide further evidence to support the notion that TET-mediated active demethylation of the KCNMB1 is critical in the adaptation of uterine circulation during pregnancy. These findings also have clinical relevance. Our previous studies revealed that highaltitude hypoxia impaired pregnancy-and estrogen-induced demethylation of KCNMB1 and ESR1 promoters, resulting in increased uterine vascular tone. 30, 31, 37 Impaired uterine circulation by gestational hypoxia has been associated with increased incidence of preeclampsia and fetal growth restriction. 12, 13, 65 A recent study demonstrated downregulation of TETs in human placenta of preeclampsia. 66 Thus, dysregulation of TETs could potentially impair expression of BK Ca channels and ERα in uterine arteries, leading to aberrant uterine perfusion and development of pregnancy complications. The present study should have an impact in advancing our understanding of epigenetic modification in the adaption and maladaptation of uterine circulation in pregnancy and provide new insights into a novel target of TET-mediated active DNA demethylation in potential therapeutic strategies that may be beneficial for the treatment of pregnancy complications including preeclampsia. Altered expression of the BK Ca channel β1 subunit and channel activity in VSMCs has been observed in various physiological and pathophysiological conditions including hypertension, diabetes mellitus, aging, hypoxia, hemorrhagic shock, and obesity. [20] [21] [22] [23] [24] [25] [26] [27] [28] It is of particular interest whether altered DNA methylationdemethylation dynamics of the KCNMB1 promoter is a generalized mechanism responsible for regulating BK Ca channel expression and function in the cardiovascular system.
Perspectives
The BK Ca channel is of critical importance in pregnancymediated increase in uterine artery vasodilation and blood flow. The present study reveals that the expression of TET1 in the uterine arteries is upregulated by estrogen during pregnancy, which drives active demethylation and subsequently increases KCNMB1 expression. The enhanced expression of KCNMB1 in turn elevates BK Ca channel activity and reduces uterine vascular tone. Thus, estrogen could function as a switch to trigger the transition from transcriptional repression of KCNMB1 in the nonpregnant state to transcriptional activation in the pregnant state through the action of TETs. The present findings demonstrate a novel mechanism of estrogenmediated active DNA demethylation in reprogramming of BK Ca channel expression and function in the adaption of uterine circulation during pregnancy and provide new insights in our understanding of pathophysiologic mechanisms underlying pregnancy complications including preeclampsia and fetal growth restriction caused by maladaptation of the uteroplacental circulation. Given that the BK Ca channel is fundamentally important in regulating vascular tone and pressure in virtually all vascular beds, revealing epigenetic regulation of BK Ca channel function in vascular smooth muscle will indeed have a much broader impact in the comprehensive understanding of molecular mechanisms in vascular physiology and pathophysiology.
